Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome

Movement Disorders

Volumn 14, Issue 3, 1999, Pages 530-532

  Lees, Andrew J ^a   Morris, Huw R ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; LEVODOPA; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; APRAXIA; ARTICLE; BRAIN INFARCTION; CASE REPORT; CORTICOBASAL DEGENERATION; DIAGNOSTIC ERROR; FEMALE; HUMAN; LIVEDO RETICULARIS; MIGRAINE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BASAL GANGLIA DISEASES; CAUDATE NUCLEUS; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; OCCIPITAL LOBE; PARIETAL LOBE; SYNDROME;

EID: 0342545943     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199905)14:3<530::AID-MDS1030>3.0.CO;2-8     Document Type: Article

References (16)

1. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
2. Thompson PD, Day BL, Rothwell JC, Brown P, Britton TC, Marsden CD. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994;117: 1197-1207.
3. Gibb WR, Luthert PJ, Marsden CD. Clinical and pathological features of corticobasal degeneration. Adv Neurol 1990;53:51-54.
4. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
5. Cannard K, Galvez-Jimenez N, Watts R. Creutzfeldt-Jakob disease presenting and evolving as rapidly progressive corticobasal degeneration [Abstract]. Neurology 1998;50:A95.
6. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-1440.
7. Giladi N, Fahn S. Hemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration. Mov Disord 1992;7:384-385.
8. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74.
9. Barclay CL, Lang AE. Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:352-356.
10. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997; 56:726-734.
11. Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997;120:75-90.
12. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181-1189.
13. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64: 184-189.
14. Angelini L, Rumi V, Nardocci N, Combi ML, Bruzzone MG, Pellegrini G. Hemidystonia symptomatic of primary antiphospho-lipid syndrome in childhood. Mov Disord 1993;8:383-386.
15. Cordova JL, Neira O, Abumohor P, Palma S, Vergara F, Guzman L. Anticardiolipin antibodies and primary antiphospholipid syndrome of the central nervous system: report of 10 clinical cases. Rev Med Chil 1991;119:765-771.
16. Sugiyama Y, Yamamoto T, Tsukamoto T, Saito T, Takahashi T. A case of chorea as a sole presentation of primary anti-phospholipid antibody syndrome. Rinsho Shinkeigaku 1991;31:1224-1228.